Authors : Behrooz Rasuli, Majid Nabavi
Facing the coronavirus disease 2019 (COVID-19) pandemic, medical publishers rose to the occasion, moving to make their full portfolio of COVID-19–related research available to read for free and expediting peer review and production processes. With such a rapid transition from paper submission to publication, however, concerns also arose regarding whether the quality of the research publication process was being affected. This article seeks to document the transformation of medical publishers’ practices in response to the COVID-19 pandemic and briefly discuss where they may go from here. For this goal, a literature search was performed in PubMed at several points to identify papers that reported early trends in how medical publishers handled COVID-19 research.